RxDoctor Payments Data
★ My doctorsLook up a doctor →

Rehana Latif

Psychiatry · Bronxville, NYNPI 1184638140

Payments from drug & device makers

$8,349in general payments, 2019–2025

Across 442 payments — averaging $18.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Lundbeck LLC$836
  • Otsuka America Pharmaceutical, Inc.$784
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$761
  • Vanda Pharmaceuticals Inc.$530
  • Sunovion Pharmaceuticals Inc.$446
  • plus $2K from 19 others

What the payments were for

  • Food & beverage$8,30299%
  • Education$471%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)182$2,701
Lundbeck LLC42$836
Otsuka America Pharmaceutical, Inc.36$784
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)31$761
Vanda Pharmaceuticals Inc.18$530
Sunovion Pharmaceuticals Inc.29$446
Bausch Health US, LLC23$440
Alkermes, Inc.16$432
Takeda Pharmaceuticals U.S.A., Inc.14$326
Johnson & Johnson9$167
Axsome Therapeutics, Inc.5$136
Neurocrine Biosciences, Inc.5$126
Adlon Therapeutics L.p.6$111
Neuronetics, Inc.2$82
Supernus Pharmaceuticals, Inc.3$70
Ironshore Pharmaceuticals Inc.4$66
Validus Pharmaceuticals LLC3$54
Brainsway USA Inc1$53
Tris Pharma Inc3$46
Eisai Inc.2$40
Shire North American Group Inc2$34
Idorsia Pharmaceuticals US Inc2$34
Arbor Pharmaceuticals, Inc.2$33
Corium, LLC1$24
Vertical Pharmaceuticals, LLC1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,349 in reported general payments places this provider in the 90th percentile of 3,713 psychiatry providers in New York.

See all psychiatry providers in New York →

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrintellixVortioxetine Hydrobromide13$9,007
Lurasidone Hcl29$7,559
Methylphenidate ErMethylphenidate Hcl17$1,554
Bupropion XlBupropion Hcl39$1,336
Duloxetine Hcl42$1,236
Amitriptyline Hcl47$1,197
Trazodone Hcl52$981
Venlafaxine Hcl ErVenlafaxine Hcl19$878
Escitalopram Oxalate74$862
Fluoxetine Hcl54$766
Clonazepam94$616
Diazepam48$571
Lamotrigine44$424
Gabapentin35$385
Aripiprazole21$381

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$326$9,00713 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,713 psychiatry providers in New York.

Other psychiatry in Bronxville

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →